Skip to main content

Motrin IB News

Early Ibuprofen Not Beneficial for Preemies With Patent Ductus Arteriosus

THURSDAY, Jan. 25, 2024 – For extremely preterm infants, the risk for death or moderate or severe bronchopulmonary dysplasia is not significantly lower among those receiving early treatment for...

Migraine? Reach for Prescription Meds, Not Ibuprofen

THURSDAY, Nov. 30, 2023 – Migraine sufferers would do better to talk to their doctor about a prescription drug than reaching for a bottle of ibuprofen, a new study finds. Drugs like triptans, ergots...

Few Adults Talk to Providers About BP Risks of OTC Pain Relievers

TUESDAY, Nov. 7, 2023 – Only about 30 percent of U.S. adults have spoken with their health care professional about the adverse effects some over-the-counter pain relievers can have on blood...

Arthritic Hands: What Works (and Doesn't) to Ease the Pain?

MONDAY, Oct. 2, 2023 – Millions of people who live with the pain and stiffness of arthritis in their hands get steroid or hyaluronic acid injections directly into their finger joints in the hopes of...

Oral NSAIDs, Glucocorticoids Seem Effective for Hand Osteoarthritis

FRIDAY, Sept. 29, 2023 – Oral nonsteroidal anti-inflammatory drugs (NASIDs) and glucocorticoids seem to be effective for hand osteoarthritis (OA), according to a review published online Sept. 28 in...

Health Issue Has Bruce Springsteen Postponing Shows for the Rest of the Year

THURSDAY, Sept. 28, 2023 – Rock star Bruce Springsteen announced Wednesday that he has postponed all of his remaining shows this year as he deals with peptic ulcer disease. Springsteen said he’s c...

Using Meds to Manage Your Arthritis Pain: An Overview

TUESDAY, Sept. 19, 2023 – Millions of Americans suffer from arthritis, and many reach for medication to ease their joint pain and inflammation. The options might seem overwhelming, though. Here, the...

Link Explored for NSAID Use, Hormonal Contraception, VTE Risk

MONDAY, Sept. 11, 2023 – In women of reproductive age, nonsteroidal anti-inflammatory drug (NSAID) use is associated with venous thromboembolism, with significantly more additional events with...

Combo of Certain Birth Control Pills, Painkillers Could Raise Women's Clot Risk

FRIDAY, Sept. 8, 2023 – It's well known that certain forms of birth control carry a small risk of blood clots. Now a large new study suggests that some common painkillers can magnify that risk. The...

Avoid Opioids for Short-Term Dental Pain in Kids, New Guidelines Say

MONDAY, Aug. 28, 2023 – Children having short-term dental pain from extractions or toothache should not be prescribed opioids but rather manage those aches with over-the-counter ibuprofen and/or...

How NSAIDs Can Make a C. Difficile Infection Worse

FRIDAY, July 21, 2023 – Aspirin, naproxen and other common pain medications known as NSAIDs worsen gastrointestinal infections caused by a bacterium known as Clostridioides difficile (C. diff), new...

FDA Medwatch Alert: Voluntary Recall of Certain Family Dollar Over-the-Counter Products

July 21, 2022 – Family Dollar is initiating a voluntary retail level product recall of certain products regulated by the U.S. Food and Drug Administration (FDA) that were stored and inadvertently...

FDA Medwatch Alert: Drug Safety Communication: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) - Avoid Use of NSAIDs in Pregnancy at 20 Weeks or Later

ISSUE: FDA is warning that use of NSAIDs around 20 weeks or later in pregnancy may cause rare but serious kidney problems in an unborn baby. This can lead to low levels of amniotic fluid surrounding...

FDA Medwatch Alert: Tris Pharma, Inc Expands Its Voluntary Nationwide Retail Recall of Ibuprofen Oral Suspension Drops, USP, 50 mg per 1.25 mL, Due to Higher Concentration of Ibuprofen

Monmouth Junction, NJ, Tris Pharma, Inc. is expanding the scope of its November 2018 recall by adding three (3) additional lots of Ibuprofen Oral Suspension Drops, USP, 50 mg per 1.25 mL, to the...

FDA Medwatch Alert: Tris Pharma Issues Voluntary Nationwide Recall of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, Due to Potential Higher Concentrations of Ibuprofen

December 5, 2018 – Tris Pharma, Inc. has voluntarily recalled three (3) lots of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, to the retail level. The recalled lots ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Back Pain, Chronic Myofascial Pain, Aseptic Necrosis, Headache, Pain, Muscle Pain, Frozen Shoulder, Gout - Acute, Fever, view more... Juvenile Rheumatoid Arthritis, Dysautonomia, Neck Pain, Osteoarthritis, Period Pain, Dysmenorrhea, Plantar Fasciitis, Rheumatoid Arthritis, Sciatica, Spondylolisthesis, Temporomandibular Joint Disorder

Motrin IB patient information at Drugs.com